Novel imaging techniques in staging oesophageal cancer. (October 2018)

• Record Type: Journal Article
• Authors: Foley, Kieran; Findlay, John; Goh, Vicky
• Is Part Of: Best practice & research. Volume 36/37(2018)
• Page Start: 17
• Page End: 25
• Publication Date: 2018-10
• Subjects: Oesophageal cancer -- TNM -- Staging -- Response -- Prognosis -- Computed tomography -- Endoscopic ultrasound -- Positron-emission tomography -- Magnetic resonance imaging; Gastroenterology -- Periodicals; Gastrointestinal system -- Diseases -- Periodicals; Gastrointestinal Diseases; Gastroenterology; Klinische geneeskunde; Gastro-enterologie; Gastroenterology; Gastrointestinal system -- Diseases; Periodicals; 616.33005
• DOI: 10.1016/j.bpg.2018.11.009
• Languages: English
• ISSNs: 1521-6918

Abstract

Abstract: The survival of oesophageal cancer is poor as most patients present with advanced disease. Radiological staging of oesophageal cancer is complex but is fundamental to clinical management. Accurate staging investigations are vitally important to guide treatment decisions and optimise patient outcomes. A combination of baseline computed tomography (CT), endoscopic ultrasound (EUS) and positron emission tomography (PET) are currently used for initial treatment decisions. The potential value of these imaging modalities to re-stage disease, monitor response and alter treatment is currently being investigated. This review presents an essential update on the accuracy of oesophageal cancer staging investigations, their use in re-staging after neo-adjuvant therapy and introduces evolving imaging techniques, including novel biomarkers that have clinical potential in oesophageal cancer.